Efficacy and safety of edifoligide. (Record no. 16201633)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01242 a2200361 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250515022328.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 200604s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1538-3598 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1001/jama.295.13.1513-a |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Parolari, Alessandro |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20060412 |
245 00 - TITLE STATEMENT | |
Title | Efficacy and safety of edifoligide. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | JAMA |
Date of publication, distribution, etc. | Apr 2006 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1513; author reply 1514-5 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Letter; Comment |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Coronary Artery Bypass |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | DNA |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | E2F Transcription Factors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Fibrinolytic Agents |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Genetic Therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Graft Occlusion, Vascular |
General subdivision | prevention & control |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Oligonucleotides |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Saphenous Vein |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Transplants |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Vascular Patency |
General subdivision | drug effects |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Alamanni, Francesco |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Tremoli, Elena |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Biglioli, Paolo |
773 0# - HOST ITEM ENTRY | |
Title | JAMA |
Related parts | vol. 295 |
-- | no. 13 |
-- | p. 1513; author reply 1514-5 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1001/jama.295.13.1513-a">https://doi.org/10.1001/jama.295.13.1513-a</a> |
Public note | Available from publisher's website |
No items available.